Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-17

FDA Approved: PRASUGREL — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for prasugrel submitted by Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)